← Back to Search

Compression Device

Dayspring Active Wearable Compression System for Lymphedema (TIBER Trial)

N/A
Waitlist Available
Research Sponsored by Koya Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

TIBER Trial Summary

This study is evaluating whether compression stockings may help reduce swelling in the legs of individuals with lymphedema.

Eligible Conditions
  • Lymphedema
  • Chronic Venous Insufficiency

TIBER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
LYMQOL (LYMphedema Quality of Life)
Limb Volume Maintenance or Improvement
Secondary outcome measures
Patient survey
Safety/AEs
Therapy adherence tracking

TIBER Trial Design

1Treatment groups
Experimental Treatment
Group I: Subjects with Lower Extremity Lymphedema and phlebolymphedemaExperimental Treatment1 Intervention
Lower Extremity Lymphedema and phlebolymphedema
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dayspring Active Wearable Compression System
2021
N/A
~60

Find a Location

Who is running the clinical trial?

Koya Medical, Inc.Lead Sponsor
5 Previous Clinical Trials
331 Total Patients Enrolled
5 Trials studying Lymphedema
331 Patients Enrolled for Lymphedema

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
Ginger-K Lymphedema & Cancer Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema
2021. "A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04897035.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top